ArticleEMBO molecular medicine2026

Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling.

Adeline Cezard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.